Transcriptional Control of Human Placental Differentiation
人类胎盘分化的转录控制
基本信息
- 批准号:8810250
- 负责人:
- 金额:$ 31.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdenovirusesAgonistBiochemicalCREB1 geneCell Differentiation processCellsCellular MorphologyDIF factorDataDefectDevelopmentDiabetes MellitusEGF geneFeedbackFetal Growth RetardationFunctional disorderGenesGrowth FactorHealthHormonesHumanHuman DevelopmentHypertensionImmunohistochemistryInsulin-Like Growth Factor IInvestigationKnowledgeLaboratoriesLeadMacrophage Colony-Stimulating FactorMaternal MortalityMessenger RNAMolecularMonitorMononuclearMorbidity - disease rateMorphologyPathogenesisPathologicPathway interactionsPatientsPhenotypePhosphorylationPlacentaPlacentationPost-Translational Protein ProcessingPre-EclampsiaPregnancyProcessProliferatingProteinsRNARegulationResearchRoleSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNAStagingSyncytiotrophoblastTFAP2A geneTestingTimeTranscription Factor AP-2 AlphaTranscriptional RegulationVillousbeta catenincytotrophoblastextracellularfetalimmunocytochemistryin vitro Modelin vivoinsightmaternal morbiditymortalityresearch studyresponsetranscription factortrophoblast
项目摘要
DESCRIPTION (provided by applicant): During the development of the human placenta, mononuclear cytotrophoblast (CTB) cells proliferate and fuse to form a syncytiotrophoblast (STB) phenotype. Although this differentiation process is critical for a successful pregnancy, the molecular mechanisms that regulate the process are poorly understood. Our laboratory, utilizing an in vitro model of human CTB cell differentiation, has shown that the transcription factor AP-21 is critical for the differentiation of villous CTB cells to a STB phenotype; and we have characterized some of the upstream regulators and downstream targets of AP-21. Our preliminary studies indicate that several extracellular factors that induce CTB cell differentiation stimulate AP-21 expression that the Wnt-beta-catenin- TCF pathway inhibits AP-21 expression during CTB cell differentiation and that AP-21 expression is abnormal in placentas from patients with severe preeclampsia. We now propose a comprehensive investigation into the mechanisms of which AP-21 regulates CTB cell to STB cell differentiation in the context of normal differentiation and in the context of pathologic conditions characterized by abnormal villous CTB differentiation, such as preeclampsia and IUGR. Specific Aim 1 tests the hypothesis that extracellular factors that induce villous CTB differentiation act, at least in part, by an AP-21-dependent mechanism. Aim 2 tests the hypothesis that there is a negative feedback loop between AP-21 and the Wnt-2-catenin pathway and that extracellular factors that induce CTB cell differentiation act at least in part by inhibiting Wnt-2-catenin-TCF signaling. Aim 3 examines the hypothesis that abnormalities in the AP-21 cascade are responsible, at least in part, for the defective villous CTB cell differentiation in preeclampsia and IUGR. The experiments will utilize an in vitro model of human CTB cell differentiation that closely mimics the in vivo differentiation process. The degree of differentiation will be monitored by cell morphology and by the expression of specific STB marker genes. The studies should provide new insights into the molecular mechanisms of placental differentiation and the pathogenesis of the defective placentation in preeclampsia and IUGR. These insights in turn may lead to development of new strategies to treat placental defects that result in fetal morbidity and mortality.
描述(由申请方提供):在人胎盘发育过程中,单核细胞滋养层(CTB)细胞增殖并融合形成合胞体滋养层(STB)表型。虽然这种分化过程对于成功怀孕至关重要,但调节这一过程的分子机制却知之甚少。我们的实验室,利用人CTB细胞分化的体外模型,已经表明,转录因子AP-21是绒毛CTB细胞分化成STB表型的关键;我们已经表征了AP-21的一些上游调控因子和下游靶点。我们的初步研究表明,诱导CTB细胞分化的几种细胞外因子刺激AP-21的表达,Wnt-β-catenin- TCF途径抑制AP-21在CTB细胞分化过程中的表达,并且AP-21在重度先兆子痫患者的胎盘中表达异常。我们现在提出了一个全面的调查机制,AP-21调节CTB细胞STB细胞分化的正常分化的背景下,并在病理条件的背景下,其特征在于异常绒毛CTB分化,如先兆子痫和IUGR。特异性目的1检验诱导绒毛CTB分化的细胞外因子至少部分通过AP-21依赖性机制起作用的假设。目的2测试AP-21和Wnt-2-连环蛋白通路之间存在负反馈环以及诱导CTB细胞分化的细胞外因子至少部分通过抑制Wnt-2-连环蛋白-TCF信号传导起作用的假设。目的3检验AP-21级联反应的异常至少部分地导致先兆子痫和IUGR中有缺陷的绒毛CTB细胞分化的假设。该实验将利用人CTB细胞分化的体外模型,其密切模拟体内分化过程。通过细胞形态学和特定STB标记基因的表达监测分化程度。这些研究为了解胎盘分化的分子机制以及子痫前期和IUGR中胎盘缺陷的发病机制提供了新的见解。这些见解反过来可能会导致新的策略来治疗导致胎儿发病率和死亡率的胎盘缺陷。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ETS1 induces human trophoblast differentiation.
- DOI:10.1210/en.2014-1760
- 发表时间:2015-02
- 期刊:
- 影响因子:4.8
- 作者:C. Kessler;J. Stanek;K. Stringer;S. Handwerger
- 通讯作者:C. Kessler;J. Stanek;K. Stringer;S. Handwerger
Abnormal expression of transcription factor activator protein-2α in pathologic placentas.
- DOI:10.1016/j.humpath.2012.01.011
- 发表时间:2012-11
- 期刊:
- 影响因子:3.3
- 作者:Sheridan, Rachel M.;Stanek, Jerzy;Khoury, Jane;Handwerger, Stuart
- 通讯作者:Handwerger, Stuart
FOXO1 expression in villous trophoblast of preeclampsia and fetal growth restriction placentas.
- DOI:10.14670/hh-30.213
- 发表时间:2015-02
- 期刊:
- 影响因子:2
- 作者:Sheridan R;Belludi C;Khoury J;Stanek J;Handwerger S
- 通讯作者:Handwerger S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE M DOLAN其他文献
LAWRENCE M DOLAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE M DOLAN', 18)}}的其他基金
SEARCH for Diabetes in Youth Registry Study, Phase 4: Ohio Center
青少年登记研究中的糖尿病搜索,第 4 阶段:俄亥俄中心
- 批准号:
9127726 - 财政年份:2015
- 资助金额:
$ 31.73万 - 项目类别:
SEARCH for Diabetes in Youth Registry Study, Phase 4: Ohio Center
青少年登记研究中的糖尿病搜索,第 4 阶段:俄亥俄中心
- 批准号:
9753809 - 财政年份:2015
- 资助金额:
$ 31.73万 - 项目类别:
SEARCH for Diabetes in Youth Registry Study, Phase 4: Ohio Center
青少年登记研究中的糖尿病搜索,第 4 阶段:俄亥俄中心
- 批准号:
9041800 - 财政年份:2015
- 资助金额:
$ 31.73万 - 项目类别:
SEARCH 3 Cohort Study to Assess Incidence of Acute and Chronic Diabetes-related C
SEARCH 3 队列研究评估急性和慢性糖尿病相关的 C 发病率
- 批准号:
8531693 - 财政年份:2010
- 资助金额:
$ 31.73万 - 项目类别:
SEARCH 3 Cohort Study to Assess Incidence of Acute and Chronic Diabetes-related C
SEARCH 3 队列研究评估急性和慢性糖尿病相关的 C 发病率
- 批准号:
8321852 - 财政年份:2010
- 资助金额:
$ 31.73万 - 项目类别:
SEARCH 3 Cohort Study to Assess Incidence of Acute and Chronic Diabetes-related C
SEARCH 3 队列研究评估急性和慢性糖尿病相关的 C 发病率
- 批准号:
8728641 - 财政年份:2010
- 资助金额:
$ 31.73万 - 项目类别:
SEARCH 3 Cohort Study to Assess Incidence of Acute and Chronic Diabetes-related C
SEARCH 3 队列研究评估急性和慢性糖尿病相关的 C 发病率
- 批准号:
8146890 - 财政年份:2010
- 资助金额:
$ 31.73万 - 项目类别:
SEARCH 3 Cohort Study to Assess Incidence of Acute and Chronic Diabetes-related C
SEARCH 3 队列研究评估急性和慢性糖尿病相关的 C 发病率
- 批准号:
8067572 - 财政年份:2010
- 资助金额:
$ 31.73万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 31.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 31.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别: